Aim to evaluate the effectiveness of providing specialized dermatovenerological care using remote telemedicine consultations to patients of the Samara region with chronic dermatoses: psoriasis, atopic dermatitis, eczema. Material and methods. We performed a comparative analysis of telemedicine consultations in real time in 53 adult patients with confirmed clinical diagnoses who were on inpatient and outpatient treatment. The results were evaluated by the duration of clinical remission and indicators of the Dermatology Life Quality Index (DLQI) 12 months after the start of treatment.The telemedicine consultations were conducted in the Unified Medical Information and Analytical System of the Samara Region (EMIAS) using the integrated video conferencing service (VCS) TrueConf version 7.5. Results. We noted the clinical effectiveness of telemedicine consultations in patients with chronic recurrent dermatoses. The duration of clinical remission significantly increased from 3.1 0.7 months to 5.7 0.4 months (p 0.05). In the comparison group, this indicator did not significantly differ (p = 0.05) from the initial one (3.2 0.1 months and 3.3 0.6 months). According to the results of the telemedicine consultations, the DLQ index had improved by an average of 45.1% and amounted to 12.4 1.8 points from the initial 22.6 1.6 points (p 0.05). The treatment compliance increased in 58.5% of patients (31 people), of which 81% (25 people) were rural residents. The remote counseling increases the availability of the medical care and satisfaction of dermatovenerological patients of the Samara region with the medical care provided.

Background. The chronic and recurrent nature of seborrheic dermatitis, its wide prevalence and multifactorial etiopathogenesis require a comparison of the effectiveness of different treatment strategies. Aim. In a randomized controlled trial to evaluate the effectiveness of standard and intermittent therapy with topical corticosteroids and activated zinc pyrithione (Skin-cap cream) in reducing the severity of clinical manifestations, the duration of remission of the disease, and compliance with treatment. Methods. The effectiveness of external therapy in patients with seborrheic dermatitis of the face and scalp was studied. All the examined patients had at least two episodes of exacerbation per year. Doctor's prescription Mometasone furoate cream 0.1% 1 time/day externally for 14 days, activated zinc pyrithione (Skin-cap cream) 2 times/day externally for 14 days, further 1 time a day 2 times a week for 14 days. Results. There was a comparable clinical effectiveness of antiinflammatory therapy in the short term with more stable results of intermittent therapy with the use of (Skin-cap cream) in the long term. Conclusions. Usage of activated zinc pyrithione (Skin-cap cream) according to the intermittent scheme in the treatment of seborrheic dermatitis of the face with the transition to the scalp is associated with long-term results. Safety of medicine allows to use it pro re nata by patients, e.g., in case of increased stress levels, diet incompliance, with no risks of adverse events, specific to topical corticosteroids, those increases treatment compliance.